Marex Group plc

Position in MRNA — Moderna, Inc.

CIK 1997464 London, X0

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,202,907

+$2,970,910 QoQ

Shares Held

88,575

+39.2% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#133

of 772 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Marex Group plc holds $88,179,553 across 55 Biotechnology names. MRNA ranks #6 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TGTX	Tg Therapeutics, Inc.	276,178	$15,173,219
2	SANA	Sana Biotechnology, Inc.	3,989,100	$13,921,959
3	NTLA	Intellia Therapeutics, Inc.	623,600	$10,551,312
4	CRSP	CRISPR Therapeutics AG	170,584	$9,303,650
5	DNLI	Denali Therapeutics Inc.	295,631	$7,603,629
6	MRNA	Moderna, Inc. This page	88,575	$6,202,907
7	QURE	uniQure N.V.	81,500	$3,753,890
8	ABVX	Abivax S.A.	27,336	$3,642,795

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,202,907	88,575	+39.2%	Shares	Defined	2026-08-14
2026-03-31	$3,231,997	63,622	+123.1%	Shares	Defined	2026-05-13
2025-12-31	$840,995	28,518	-87.9%	Shares	Defined	2026-02-12
2025-09-30	$6,105,049	236,355	+1718.3%	Shares	Defined	2025-11-14
2025-06-30	$358,642	12,999	-90.0%	Shares	Defined	2025-08-19
2025-03-31	$3,682,664	129,900	+49.5%	Shares	Defined	2026-04-02
2024-12-31	$3,613,301	86,900	+351.1%	Shares	Defined	2026-04-02
2024-09-30	$1,287,479	19,265	+25.5%	Shares	Defined	2026-04-07
2024-06-30	$1,822,218	15,345	-7.5%	Shares	Defined	2026-04-02
2024-03-31	$1,768,363	16,595	+16.1%	Shares	Defined	2026-04-02
2023-12-31	$1,421,140	14,290	+68.8%	Shares	Defined	2026-04-02
2023-09-30	$874,349	8,465	+29.5%	Shares	Defined	2026-04-02
2023-03-31	$1,003,645	6,535	-75.8%	Shares	Defined	2026-04-02
2022-12-31	$4,847,225	26,986	—	Shares	Defined	2026-04-02
No filing history on record for this holder in this stock.